4
Changes in Ownership
Syndax Pharmaceuticals Inc Filed Acc 0001562180-23-005152
Chief Financial Officer sold 577 shares at $22.31 ($12,873)
From the SEC's structured data for this filing
Trades in this filing
Goldan Keith A. · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-13 | Sale : show line 1 in the form | −577 | $22.31 | $12,873 | 2,628 | D |
| Open-market sales · 577 sh · avg $22.31 · $12,873 | ||||||
Loading xslF345X04/primarydocument.xml…